Pascal and Francis Bibliographic Databases

Help

Search results

Your search

is.\*:("DDREDK")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 2063

  • Page / 83
Export

Selection :

  • and

FLT3 antibody-based therapy for leukemiaYIWEN LI.Drug development research. 2006, Vol 67, Num 6, pp 495-500, issn 0272-4391, 6 p.Article

Heme oxygenase-1: A new drug target in oxidative tissue injuries in critically III conditionsTAKAHASHI, Toru; SHIMIZU, Hiroko; AKAGI, Reiko et al.Drug development research. 2006, Vol 67, Num 2, pp 130-153, issn 0272-4391, 24 p.Article

Further studies on the interaction of loperamide with capacitative calcium entry in leukemic HL-60 cellsDALY, John W; CAMERINI-OTERO, Carol; SHAPIRO, Craig A et al.Drug development research. 2006, Vol 67, Num 11, pp 842-851, issn 0272-4391, 10 p.Article

Induction of G2/M phase arrest and apoptosis by a novel indoloquinoline derivative, IQDMA, in K562 cellsLIN, Yi-Hsiung; YANG, Sheng-Huei; CHIEN, Ching-Ming et al.Drug development research. 2006, Vol 67, Num 9, pp 743-751, issn 0272-4391, 9 p.Article

Monoclonal antibodies : A morphing landscape for therapeuticsNICOLAIDES, Nicholas C; SASS, Philip M; GRASSO, Luigi et al.Drug development research. 2006, Vol 67, Num 10, pp 781-789, issn 0272-4391, 9 p.Article

Quinoline antimalarials as investigational drugs for HIV-1/AIDS : In vitro effects on HIV-1 replication, HIV-1 response to antiretroviral drugs, and intracellular antiretroviral drug concentrationsSAVARINO, Andrea; LUCIA, Mothanje B; TER HEINE, Rob et al.Drug development research. 2006, Vol 67, Num 10, pp 806-817, issn 0272-4391, 12 p.Article

Ultrasound-mediated therapies using oil and perfluorocarbon-filled nanodropletsDAYTON, Paul A; MATSUNAGA, Terry O.Drug development research. 2006, Vol 67, Num 1, pp 42-46, issn 0272-4391, 5 p.Article

Targeted molecular brachytherapyMAYORS, George L.Drug development research. 2006, Vol 67, Num 1, pp 94-106, issn 0272-4391, 13 p.Article

Medication effectiveness studies in the united states veterans administration health care system : A model for large integrated delivery systemsKAZIS, Lewis E; NETHERCOT, Victoria A; REN, Xinhua S et al.Drug development research. 2006, Vol 67, Num 3, pp 217-226, issn 0272-4391, 10 p.Article

Emerging drug discovery strategies for alleviating neuropathic painJARVIS, Michael F.Drug development research. 2006, Vol 67, Num 4, issn 0272-4391, 131 p.Serial Issue

Behavioral assessment of neuropathic pain in preclinical modelsHONORE, Prisca.Drug development research. 2006, Vol 67, Num 4, pp 302-307, issn 0272-4391, 6 p.Article

Modulation of neurotrophic growth factors as a therapeutic strategy for neuropathic painSAH, Dinah Y. W; PORRECA, Frank; OSSIPOV, Michael H et al.Drug development research. 2006, Vol 67, Num 4, pp 389-403, issn 0272-4391, 15 p.Article

Glucocorticoids in type 2 diabetes mellitus and the metabolic syndromeWELLES, Bernice.Drug development research. 2006, Vol 67, Num 7, pp 570-573, issn 0272-4391, 4 p.Conference Paper

Postprandial hyperglycemia : Why do we care about it? What should we do?RENDELL, Marc S.Drug development research. 2006, Vol 67, Num 7, pp 582-586, issn 0272-4391, 5 p.Conference Paper

Male hypogonadism and the metabolic syndrome : Lessons from clinical studiesRODZVILLA, John P.Drug development research. 2006, Vol 67, Num 7, pp 612-615, issn 0272-4391, 4 p.Conference Paper

The metabolic syndrome : Linking oxidative stress and inflammation to obesity, type 2 diabetes, and the syndromeDANDONA, Paresh; GHANIM, Husam; MOHANTY, Priya et al.Drug development research. 2006, Vol 67, Num 7, pp 619-626, issn 0272-4391, 8 p.Conference Paper

A quantitative approach to probe the dependence and correlation of food-effect with aqueous solubility, dose/solubility ratio, and partition coefficient (Log P) for orally active drugs administered as immediate-release formulationsSINGH, Brahma N.Drug development research. 2005, Vol 65, Num 2, pp 55-75, issn 0272-4391, 21 p.Article

Design of new potent hypolipidemic agents with the synergistic structural properties of α-asarone and fibratesZUNIGA, Clara; GARDUNO, Leticia; DEL CARMEN CRUZ, Maria et al.Drug development research. 2005, Vol 64, Num 1, pp 28-40, issn 0272-4391, 13 p.Article

Development of colon-targeted albendazole -β -cyclodextrin -complex drug delivery systemsSHYALE, Somashekar; CHOWDHARY, K. P. R; KRISHNAIAH, Y. S. R et al.Drug development research. 2005, Vol 65, Num 2, pp 76-83, issn 0272-4391, 8 p.Article

Influence of preparation conditions on the properties of eudragit microspheres produced by a double emulsion methodSIPOS, Péter; CSOKA, Ildiko; SRCIC, Stane et al.Drug development research. 2005, Vol 64, Num 1, pp 41-54, issn 0272-4391, 14 p.Article

Physiological regulation of acute inflammation by A2A adenosine receptorLUKASHEV, Dmitriy E; OHTA, Akio; SITKOVSKY, Michail V et al.Drug development research. 2005, Vol 64, Num 3, pp 172-177, issn 0272-4391, 6 p.Article

Quantitative structure-activity relationship studies of cyclooxygenase inhibitors : A comprehensive analysisPRASANNA, S; MANIVANNAN, E; CHATURVEDI, S. C et al.Drug development research. 2005, Vol 64, Num 4, pp 220-231, issn 0272-4391, 12 p.Article

Rapid NMR-based functional screening and IC50 measurements performed at unprecedentedly low enzyme concentrationDALVIT, Claudio; PAPEO, Gianluca; MONGELLI, Nicola et al.Drug development research. 2005, Vol 64, Num 2, pp 105-113, issn 0272-4391, 9 p.Article

CJX2, an amlodipine derivative, reverses p-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cellsJI, Bian-Sheng; LING HE; LIU, Guo-Qing et al.Drug development research. 2005, Vol 66, Num 4, pp 278-285, issn 0272-4391, 8 p.Article

Characterization of cytochrome P450 enzymes and P-glycoprotein involved in the metabolism and transport of a new anti-angiogenic agent KR-31831HUI HYUN KIM; HYE YOUNG JI; HYE WON LEE et al.Drug development research. 2005, Vol 66, Num 1, pp 40-49, issn 0272-4391, 10 p.Article

  • Page / 83